Form D · Biotechnology
DIOMICS Corp
San Diego, CA · CIK 0001605831
Offering snapshot reported Feb 1, 2017 · SEC filing
- Reported sold
- $347K Indefinite offering
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $3.5K Reported outside-investor minimum
- First sale
- Nov 21, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 1, 2017 | Initial | $347,400 | No comparison | 15 | SEC filing |
| Oct 1, 2014 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Jun 19, 2014 | Amendment | $1,401,222 | $297,222vs Apr 29, 2014 | 8 | SEC filing |
| Jun 19, 2014 | Amendment | $505,000 | $305,000vs May 27, 2014 | 6 | SEC filing |
| May 27, 2014 | Initial | $200,000 | No comparison | 2 | SEC filing |
| Apr 29, 2014 | Initial | $1,104,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-279731
Source: Form D, filed Feb 1, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kirk Avery | Director |
| William Ballard | Director, Executive |
| Paul Buss | Director |
| Kevin Butler | Director |
| Edward Jenks | Executive |
| John Steel, Iv | Director, Executive |
| James Woodcock | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10581 Roselle Street, Suite 120
San Diego, CA, 92121
San Diego, CA, 92121